Get started
Author

James Cruise

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 566
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 512
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 402
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 361
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 303
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 141
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism
2020 · Shona C. Moore, Rebekah Penrice-Randal, et al. · Viruses · 121
PDF
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study
2022 · Douglas L Fink, Helen Callaby, et al. · The Lancet Infectious Diseases · 103
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 45
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 42
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 15
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 12
PDF
A ‘train the trainers’ approach to infection prevention and control training in pandemic conditions
2023 · Kathryn A. Haigh, Francesca Liuzzi, et al. · Clinical Infection in Practice · 9
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 8
Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard
2021 · Alexander J Stockdale, Fred Fyles, et al. · Journal of Infection · 7
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 5
PDF
Multi-species plasmids and K. pneumoniae clonal spread driving bla NDM outbreak across seven UK healthcare sites
2025 · Caitlin Duggan, Charlotte Brookfield, et al. · medRxiv · 2
PDF
Photo Quiz: Disseminated Violaceous Skin Lesions following Allogeneic Stem Cell Transplant
2021 · Hugh Adler, James Cruise, et al. · Journal of Clinical Microbiology · 1
Multi-species plasmids and K. pneumoniae clonal spread contribute to bla NDM outbreak across seven UK healthcare sites
2026 · Caitlin Duggan, Charlotte Brookfield, et al. · JAC-Antimicrobial Resistance
PDF
Genotypic-phenotypic discordance for cefiderocol against Enterobacter hormaechei
2026 · Vineet Dubey, Alessandro Gerada, et al. · International Journal of Infectious Diseases
PDF
Comparison of multiple cefiderocol susceptibility testing methods against genomic determinants of resistance in bla NDM carbapenemase producing Enterobacterales
2026 · Caitlin Duggan, Daire Cantillon, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Answer to March 2021 Photo Quiz
2021 · Hugh Adler, James Cruise, et al. · Journal of Clinical Microbiology
Works count: 22
Citation count: 2,655
H-index: 12
I10-index: 12
Year
Topic
Type